Cabot Corporation

Report azionario NYSE:CBT

Capitalizzazione di mercato: US$4.5b

Cabot Performance degli utili passati

Criteri Il passato verificati 2/6

Cabot ha registrato una crescita degli utili a un tasso medio annuo di 25.8%, mentre il settore Chemicals ha registrato utili in diminuzione a un tasso medio annuo di 3.8%. I ricavi sono stati in crescita a un tasso medio annuo di 1.6%. Il ritorno sul capitale proprio di Cabot è 19.4% e ha margini netti di 7.9%.

Informazioni chiave

25.81%

Tasso di crescita degli utili

26.74%

Tasso di crescita dell'EPS

Chemicals Crescita del settore12.93%
Tasso di crescita dei ricavi1.65%
Rendimento del capitale proprio19.38%
Margine netto7.86%
Prossimo aggiornamento sugli utili03 Aug 2026

Aggiornamenti sulle prestazioni recenti

Recent updates

Aggiornamento narrativa Jun 26

CBT: Battery Materials And Buybacks Will Shape Balanced Medium-Term Outlook

Analysts have nudged their fair value estimate for Cabot higher to $88.50 from $85.67, citing updated price targets in the $70 to $98 range and renewed attention on the company’s battery materials, Reinforcement Materials, and Performance Chemicals businesses. Analyst Commentary Recent Street commentary on Cabot gives a mixed but useful read on how professionals are weighing the company’s earnings potential, valuation, and execution across its key segments, especially battery materials, Reinforcement Materials, and Performance Chemicals.
Nuova narrativa Jun 23

Battery And Data Center Demand Will Drive Long-Term Upside Potential

Catalysts About Cabot Cabot develops specialty materials, including reinforcement and performance chemicals used across tires, batteries and broader industrial applications. What are the underlying business or industry changes driving this perspective?
Seeking Alpha Jun 22

Cabot: Battery Materials Business Growing On Gigafactory & Data-Centre Demand

Summary Cabot Corporation has demonstrated unexpected resilience, with shares up nearly 40% year-to-date and technical momentum signaling further upside potential. Upgrading CBT to 'Hold' as strong buying volume and a bullish MACD crossover suggest a possible golden cross, pending confirmation. Battery Materials led Q2 with 43% top-line growth, driving Performance Chemicals operating profit close to $60 million and fueling positive EPS revisions. Despite margin pressure in Reinforcement Materials, management guides for sequential EBIT improvement, while mission-critical products underpin long-term demand. Read the full article on Seeking Alpha
Articolo di analisi Jun 21

Cabot (CBT) Stock Could Be 7.2% Overvalued After Sixth Straight EcoVadis Platinum Rating

Cabot (CBT) has drawn fresh attention after receiving a platinum rating from EcoVadis for the sixth consecutive year, placing the company among the top 1% of peers in environmental, social, and governance practices. See our latest analysis for Cabot. The EcoVadis recognition has arrived during a strong run in Cabot’s stock, with a 34.09% 3 month share price return and a 28.47% 1 year total shareholder return, which may indicate building momentum rather than a short lived spike. If Cabot’s...
Nuova narrativa Jun 09

Battery And Data Center Demand Will Support A Steady Long Term Materials Story

Catalysts About Cabot Cabot develops and supplies specialty materials, including reinforcement materials and performance chemicals used across batteries, tires, data centers and infrastructure applications. What are the underlying business or industry changes driving this perspective?
Articolo di analisi Nov 03

Should You Think About Buying Cabot Corporation (NYSE:CBT) Now?

While Cabot Corporation ( NYSE:CBT ) might not have the largest market cap around , it saw significant share price...
Articolo di analisi Sep 11

Cabot Corporation (NYSE:CBT) Screens Well But There Might Be A Catch

With a price-to-earnings (or "P/E") ratio of 10.1x Cabot Corporation ( NYSE:CBT ) may be sending bullish signals at the...
Articolo di analisi Jul 20

Is Cabot Corporation (NYSE:CBT) Trading At A 36% Discount?

Key Insights Cabot's estimated fair value is US$117 based on 2 Stage Free Cash Flow to Equity Cabot's US$74.90 share...
Articolo di analisi Jun 23

Shareholders Would Enjoy A Repeat Of Cabot's (NYSE:CBT) Recent Growth In Returns

There are a few key trends to look for if we want to identify the next multi-bagger. Ideally, a business will show two...
Articolo di analisi Apr 25

These 4 Measures Indicate That Cabot (NYSE:CBT) Is Using Debt Reasonably Well

Howard Marks put it nicely when he said that, rather than worrying about share price volatility, 'The possibility of...
Articolo di analisi Apr 10

Cabot Corporation's (NYSE:CBT) Intrinsic Value Is Potentially 56% Above Its Share Price

Key Insights The projected fair value for Cabot is US$126 based on 2 Stage Free Cash Flow to Equity Cabot is estimated...
Articolo di analisi Mar 12

A Piece Of The Puzzle Missing From Cabot Corporation's (NYSE:CBT) Share Price

Cabot Corporation's ( NYSE:CBT ) price-to-earnings (or "P/E") ratio of 11x might make it look like a buy right now...
Seeking Alpha Feb 13

Cabot Corporation: Reinforcing Positive Shareholder Value

Summary Cabot Corporation outperforms its sector, offering growth and income opportunities, making it a strong buy candidate. CBT's two segments, Reinforcement Materials and Performance Chemicals, show impressive EBIT margin growth and revenue recovery. CBT's growing EPS, strong cash flow, and aggressive share buyback program enhance its financial resilience and shareholder value. Trading near support levels, CBT offers good upside potential with a forward yield of 2%, despite potential tariff policy risks. Read the full article on Seeking Alpha
Seeking Alpha Jan 30

Cabot: Eyeing Up A Bearish Position As We Approach Q1 Earnings (Technical Analysis)

Summary Cabot Corporation had a recent 25% drop and bearish MACD crossover, signaling potential technical weakness. The Reinforcement Materials segment continues to drive growth, but recent EPS and revenue revisions indicate challenges ahead. Fiscal 2024 revenue growth was flat, contrasting with a 5-year average of 4.59%, raising concerns about sustaining double-digit EPS growth. We expect earnings growth in Reinforcement Materials and a recovery in Performance Chemicals, but revenue growth remains crucial for CBT's long-term success. Read the full article on Seeking Alpha
Articolo di analisi Jan 29

Is There Now An Opportunity In Cabot Corporation (NYSE:CBT)?

Cabot Corporation ( NYSE:CBT ), might not be a large cap stock, but it received a lot of attention from a substantial...
Articolo di analisi Jan 15

Is Cabot (NYSE:CBT) Using Too Much Debt?

Howard Marks put it nicely when he said that, rather than worrying about share price volatility, 'The possibility of...
Articolo di analisi Jan 02

Returns On Capital Are A Standout For Cabot (NYSE:CBT)

Finding a business that has the potential to grow substantially is not easy, but it is possible if we look at a few key...
Articolo di analisi Dec 06

Cabot Corporation (NYSE:CBT) Shares Could Be 31% Below Their Intrinsic Value Estimate

Key Insights The projected fair value for Cabot is US$150 based on 2 Stage Free Cash Flow to Equity Current share price...
Seeking Alpha Nov 14

Cabot: Less Than 5% Annualized Upside

Summary Cabot Corporation has delivered a 50% total return in 1.5 years, surpassing expectations, but now trades at a premium valuation. Despite strong earnings and growth, Cabot's current valuation limits its upside, making it a "Hold" with a price target of $115/share. The company's fundamentals are solid, but market-beating returns are unlikely at current levels, prompting consideration for rotation into undervalued stocks. Cabot fulfills quality criteria but fails on valuation, justifying a cautious stance and potential sale above $115/share. Read the full article on Seeking Alpha
Articolo di analisi Oct 31

Here's Why We Think Cabot (NYSE:CBT) Might Deserve Your Attention Today

Investors are often guided by the idea of discovering 'the next big thing', even if that means buying 'story stocks...
Articolo di analisi Oct 19

Is There Now An Opportunity In Cabot Corporation (NYSE:CBT)?

Cabot Corporation ( NYSE:CBT ), is not the largest company out there, but it led the NYSE gainers with a relatively...
Articolo di analisi Oct 07

Improved Earnings Required Before Cabot Corporation (NYSE:CBT) Shares Find Their Feet

When close to half the companies in the United States have price-to-earnings ratios (or "P/E's") above 19x, you may...
Articolo di analisi Sep 25

Cabot (NYSE:CBT) Is Achieving High Returns On Its Capital

If you're looking for a multi-bagger, there's a few things to keep an eye out for. Firstly, we'd want to identify a...
Articolo di analisi Aug 19

Calculating The Intrinsic Value Of Cabot Corporation (NYSE:CBT)

Key Insights The projected fair value for Cabot is US$96.50 based on 2 Stage Free Cash Flow to Equity With US$99.26...
Seeking Alpha Jul 31

Cabot Corporation: Now A 'Hold' (Rating Downgrade)

Summary Cabot Corporation has seen significant positive performance, up over 44% inclusive of dividends since January 19, 2023. The company has outperformed with good overall investment performance, showing resilience towards macro challenges. Despite recent growth, Cabot is now considered a "Hold" due to valuation concerns and moderate upside potential. Read the full article on Seeking Alpha
Articolo di analisi Jul 18

Cabot (NYSE:CBT) Will Pay A Dividend Of $0.43

Cabot Corporation's ( NYSE:CBT ) investors are due to receive a payment of $0.43 per share on 13th of September. Based...

Ripartizione dei ricavi e delle spese

Come Cabot guadagna e spende denaro. In base agli ultimi utili dichiarati, su base LTM.


Storico di utili e ricavi

NYSE:CBT Ricavi, spese e utili (USD Millions )
DataRicaviUtiliSpese G+ASpese di R&S
31 Mar 263,57528126256
31 Dec 253,60730626056
30 Sep 253,71332625857
30 Jun 253,81541826360
31 Mar 253,90842626961
31 Dec 243,99141728062
30 Sep 243,99437428163
30 Jun 243,95847028060
31 Mar 243,91044326959
31 Dec 233,92443326059
30 Sep 233,93143725357
30 Jun 234,07830024257
31 Mar 234,25931523758
31 Dec 224,31834824655
30 Sep 224,32120625555
30 Jun 224,11314229056
31 Mar 223,88113030656
31 Dec 213,6319829755
30 Sep 213,40924729356
30 Jun 213,164-5431557
31 Mar 212,765-14429654
31 Dec 202,633-21929257
30 Sep 202,614-23829557
30 Jun 202,7826524654
31 Mar 203,10910326157
31 Dec 193,24312726858
30 Sep 193,33715527060
30 Jun 193,36021728165
31 Mar 193,36927328266
31 Dec 183,3437729567
30 Sep 183,242-11429566
30 Jun 183,115-13628264
31 Mar 182,966-17727961
31 Dec 172,8266926359
30 Sep 172,71724625857
30 Jun 172,61322527053
31 Mar 172,52923426951
31 Dec 162,41920926449
30 Sep 162,41114526648
30 Jun 162,46313625149
31 Mar 162,536-36625652
31 Dec 152,662-38826354
30 Sep 152,871-33627158

Guadagni di qualità: CBT ha guadagni di alta qualità.

Margine di profitto in crescita: Gli attuali margini di profitto netti di CBT (7.9%) sono inferiori rispetto allo scorso anno (10.9%).


Flusso di cassa libero e analisi degli utili


Analisi della crescita degli utili nel passato

Andamento degli utili: CBT è diventata redditizia negli ultimi 5 anni, aumentando i guadagni del 25.8% all'anno.

Accelerare la crescita: CBT ha avuto una crescita negativa degli utili nell'ultimo anno, quindi non può essere confrontata con la sua media quinquennale.

Guadagni vs Settore: CBT ha avuto una crescita negativa degli utili ( -34% ) nell'ultimo anno, rendendo difficile il confronto con la media del settore Chemicals ( -1.4% ).


Rendimento del capitale proprio

ROE elevato: Il Return on Equity ( 19.4% ) di CBT è considerato basso.


Rendimento delle attività


Rendimento del capitale investito


Scoprire le aziende con forti performance passate

Analisi aziendale e situazione dei dati finanziari

DatiUltimo aggiornamento (ora UTC)
Analisi dell'azienda2026/07/13 02:36
Prezzo dell'azione a fine giornata2026/07/13 00:00
Utili2026/03/31
Utili annuali2025/09/30

Fonti dei dati

I dati utilizzati nella nostra analisi aziendale provengono da S&P Global Market Intelligence LLC. I seguenti dati sono utilizzati nel nostro modello di analisi per generare questo report. I dati sono normalizzati, il che può comportare un ritardo nella disponibilità della fonte.

PacchettoDatiTempisticaEsempio Fonte USA *
Dati finanziari della società10 anni
  • Conto economico
  • Rendiconto finanziario
  • Bilancio
Stime di consenso degli analisti+3 anni
  • Previsioni finanziarie
  • Obiettivi di prezzo degli analisti
Prezzi di mercato30 anni
  • Prezzi delle azioni
  • Dividendi, scissioni e azioni
Proprietà10 anni
  • Top azionisti
  • Insider trading
Gestione10 anni
  • Team di leadership
  • Consiglio di amministrazione
Sviluppi principali10 anni
  • Annunci aziendali

* Esempio per i titoli statunitensi, per i titoli non statunitensi si utilizzano forme e fonti normative equivalenti.

Se non specificato, tutti i dati finanziari si basano su un periodo annuale ma vengono aggiornati trimestralmente. Si tratta dei cosiddetti dati TTM (Trailing Twelve Month) o LTM (Last Twelve Month). Per saperne di più.

Modello di analisi e Snowflake

I dettagli del modello di analisi utilizzato per generare questo report sono disponibili sulla nostra pagina GitHub; abbiamo anche delle guide su come utilizzare i nostri report e dei tutorial su YouTube.

Scoprite il team di livello mondiale che ha progettato e realizzato il modello di analisi Simply Wall St.

Metriche di settore e industriali

Le nostre metriche di settore e di sezione sono calcolate ogni 6 ore da Simply Wall St; i dettagli del nostro processo sono disponibili su Github.

Fonti analitiche

Cabot Corporation è coperta da 11 analisti. 6 di questi analisti ha fornito le stime di fatturato o di utile utilizzate come input per il nostro report. Le stime degli analisti vengono aggiornate nel corso della giornata.

AnalistaIstituzione
Benjamin KalloBaird
Michael LeitheadBarclays
David BegleiterDeutsche Bank